Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Boehringer Ingelheim
Moodys
Mallinckrodt
Colorcon

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Heather Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for HEATHER, and what generic and branded alternatives to HEATHER drugs are available?

HEATHER has twenty-six approved drugs.



Summary for Heather
US Patents:0
Tradenames:18
Ingredients:18
NDAs:26
Patent Litigation for Heather: See patent lawsuits for Heather

Drugs and US Patents for Heather

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heather PREDNISONE prednisone TABLET;ORAL 080320-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Heather METHYLTESTOSTERONE methyltestosterone CAPSULE;ORAL 084967-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Heather TRIPELENNAMINE HYDROCHLORIDE tripelennamine hydrochloride TABLET;ORAL 083989-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Heather DOXYCYCLINE HYCLATE doxycycline hyclate CAPSULE;ORAL 062463-001 Dec 7, 1983 DISCN No No   Start Trial   Start Trial
Heather SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim TABLET;ORAL 018946-002 Aug 10, 1984 DISCN No No   Start Trial   Start Trial
Heather MEPROBAMATE meprobamate TABLET;ORAL 016928-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Heather SULFISOXAZOLE sulfisoxazole TABLET;ORAL 080189-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Moodys
Mallinckrodt
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.